New World Evidence Data Market, By Component (Dataset (Claims, Clinical, Pharmacy, and Patient) and Services), By Therapeutic Area (Oncology, Cardiovascular, and Immunology), By End-User (Pharmaceuticals, Medical Devices, Payers, and Providers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

New World Evidence Market is expected to reach US$ 7.2 billion by 2034, growing at a compound annual growth rate of 6.1% from its estimated US$ 1.9 billion in 2024.

By gathering evidence from a variety of sources, including clinical and real-world evidence about the uses, dangers, and advantages of a medical product obtained through the analysis of real-world data (RWD), the New World Evidence Data Market focuses on providing data regarding the patient's health status and healthcare.

The primary driver of the target market's expansion is the growing incidence of chronic diseases in general and among the senior population in particular. The New World Evidence Data Market is expected to expand as a result of the increasing number of patients with various chronic conditions, which raises the need for and demand for smart data storage.

For example, in 2016, the Health IT Buzz estimated that approximately 96% of hospitals and 78% of physicians had been utilizing approved electronic health record systems in the US.